Key result
Voncento provides effective and well-tolerated peri-operative management across all inherited vWD types.
Key points are not available for this paper at this time.
Population
Patients with inherited VWD undergoing surgery
Design
Multicentre observational study
Answers are grounded in this paper and cite their sources.
Supports perioperative Voncento use in inherited VWD; observational data leaves open need for randomized confirmation.
BACKGROUND: (CSL Behring, Marburg, Germany), a plasma-derived FVIII/VWF concentrate (ratio 1:2.4), during surgeries performed in patients with inherited VWD. MATERIALS AND METHODS: who underwent surgery. RESULTS: were recorded. DISCUSSION: is an effective and well-tolerated therapy for the peri-operative management of patients with all VWD types.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied this question. The hFVIII/VWF concentrate Voncento is an effective and well-tolerated therapy for the peri-operative management of patients with all types of inherited von Willebrand disease.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: